Redmile Group’s Arvinas ARVN Stock Holding History

Redmile Group’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150,955	Closed	-$2.23M	–	84
2019 Q1	$2.23M	Buy	150,955 +14,655	+11%	+$260K	0.07%	64
2018 Q4	$1.75M	Hold	136,300	–	–	0.07%	63
2018 Q3	$2.3M	Buy	+136,300	New	+$2.24M	0.07%	67

Other funds holding ARVN

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Redmile Group's ARVN Position: Q2 2019 in Review

Redmile Group sold out of Arvinas (ARVN) in Q2 2019, closing a stake of 150,955 shares — an estimated $2.23M sold.

Redmile Group first reported a position in ARVN in Q3 2018 and held it in 3 quarters. The position peaked at $2.3M in Q3 2018. 67 funds tracked by Wall St. Rank hold ARVN as of Q2 2019.

Redmile Group reported no remaining Arvinas position as of Q2 2019 after selling out during the quarter.
Redmile Group sold 150,955 Arvinas shares in Q2 2019, an estimated $2.23M.
Redmile Group first reported a position in Arvinas in Q3 2018 and held it in 3 quarters.
Redmile Group's Arvinas position peaked at $2.3M in Q3 2018.
67 funds tracked by Wall St. Rank held Arvinas as of Q2 2019.

Based on Redmile Group's 13F filing for Q2 2019, filed 14 Aug 2019.